CH583713A5 - - Google Patents

Info

Publication number
CH583713A5
CH583713A5 CH952873A CH952873A CH583713A5 CH 583713 A5 CH583713 A5 CH 583713A5 CH 952873 A CH952873 A CH 952873A CH 952873 A CH952873 A CH 952873A CH 583713 A5 CH583713 A5 CH 583713A5
Authority
CH
Switzerland
Application number
CH952873A
Original Assignee
Cermol Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cermol Sa filed Critical Cermol Sa
Priority to CH952873A priority Critical patent/CH583713A5/xx
Priority to CH870976A priority patent/CH585209A5/xx
Priority to US05/481,794 priority patent/US3940386A/en
Priority to IL45107A priority patent/IL45107A0/xx
Priority to SE7408344A priority patent/SE7408344L/xx
Priority to NLAANVRAGE7408507,A priority patent/NL184682C/xx
Priority to FR7422314A priority patent/FR2234898B1/fr
Priority to CA203,446A priority patent/CA1025452A/en
Priority to ES427682A priority patent/ES427682A1/es
Priority to AR254454A priority patent/AR203031A1/es
Priority to FI1996/74A priority patent/FI199674A/fi
Priority to BE145991A priority patent/BE816984A/xx
Priority to DK348374A priority patent/DK348374A/da
Priority to GB2873674A priority patent/GB1461689A/en
Priority to DE2431178A priority patent/DE2431178C2/de
Priority to AT539374A priority patent/AT340932B/de
Priority to JP49074918A priority patent/JPS6037095B2/ja
Publication of CH583713A5 publication Critical patent/CH583713A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/48—Aldehydo radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CH952873A 1973-06-29 1973-06-29 CH583713A5 (cs)

Priority Applications (17)

Application Number Priority Date Filing Date Title
CH952873A CH583713A5 (cs) 1973-06-29 1973-06-29
CH870976A CH585209A5 (cs) 1973-06-29 1973-06-29
US05/481,794 US3940386A (en) 1973-06-29 1974-06-21 Substituted cinnamoyl-piperazine-pyridyl compound
IL45107A IL45107A0 (en) 1973-06-29 1974-06-24 Substituted piperazines
SE7408344A SE7408344L (cs) 1973-06-29 1974-06-25
NLAANVRAGE7408507,A NL184682C (nl) 1973-06-29 1974-06-25 Werkwijze voor de bereiding van piperazine-derivaten met anti-histamine-werking en werkwijze voor de bereiding van farmaceutische preparaten die ze bevatten.
FR7422314A FR2234898B1 (cs) 1973-06-29 1974-06-26
CA203,446A CA1025452A (en) 1973-06-29 1974-06-26 Substituted piperazines
ES427682A ES427682A1 (es) 1973-06-29 1974-06-26 Un procedimiento para la preparacion de piperazinas.
AR254454A AR203031A1 (es) 1973-06-29 1974-06-27 Procedimiento de preparacion de piperazinas n,n bisustituidas
FI1996/74A FI199674A (cs) 1973-06-29 1974-06-27
BE145991A BE816984A (fr) 1973-06-29 1974-06-27 Piperazines substituees
DK348374A DK348374A (cs) 1973-06-29 1974-06-28
GB2873674A GB1461689A (en) 1973-06-29 1974-06-28 Substituted piperazines
DE2431178A DE2431178C2 (de) 1973-06-29 1974-06-28 Piperazinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneipräparate
AT539374A AT340932B (de) 1973-06-29 1974-06-28 Verfahren zur herstellung von neuen piperazinderivaten und deren salzen
JP49074918A JPS6037095B2 (ja) 1973-06-29 1974-06-29 ピペラジン置換体の製法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH952873A CH583713A5 (cs) 1973-06-29 1973-06-29
CH870976A CH585209A5 (cs) 1973-06-29 1973-06-29
CH689974 1974-05-20

Publications (1)

Publication Number Publication Date
CH583713A5 true CH583713A5 (cs) 1977-01-14

Family

ID=27175623

Family Applications (2)

Application Number Title Priority Date Filing Date
CH952873A CH583713A5 (cs) 1973-06-29 1973-06-29
CH870976A CH585209A5 (cs) 1973-06-29 1973-06-29

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH870976A CH585209A5 (cs) 1973-06-29 1973-06-29

Country Status (10)

Country Link
US (1) US3940386A (cs)
JP (1) JPS6037095B2 (cs)
AT (1) AT340932B (cs)
BE (1) BE816984A (cs)
CA (1) CA1025452A (cs)
CH (2) CH583713A5 (cs)
DE (1) DE2431178C2 (cs)
FR (1) FR2234898B1 (cs)
GB (1) GB1461689A (cs)
NL (1) NL184682C (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4068070A (en) * 1974-07-16 1978-01-10 Fuji Chemical Industry Co., Ltd. α-Cyanoamine compounds and a process for producing the same
US4001223A (en) * 1975-01-13 1977-01-04 Idemitsu Kosan Co., Ltd. Adamantane-piperazine derivatives
FR2387971A1 (fr) * 1977-04-19 1978-11-17 Delalande Sa Nouvelles trimethoxy cinnamoyles piperazines, leur procede de preparation et leur application en therapeutique
US4368199A (en) * 1980-01-21 1983-01-11 Delalande S.A. Novel derivatives of 3,4,5-trimethoxy cinnamoyl piperazine, their salts, the process for preparing the same and their application in therapeutics
FR2474031A1 (fr) * 1980-01-21 1981-07-24 Delalande Sa Nouveaux derives de la trimethoxy-3,4,5 cinnamoyle piperazine, leurs sels, leur procede de preparation et leur application en therapeutique
DE3167049D1 (de) * 1980-06-16 1984-12-13 Ferrosan Ab Diphenylbutyl-1-acylpiperazines
SE9504661D0 (sv) * 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
US6288083B1 (en) 1998-09-04 2001-09-11 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6503926B2 (en) 1998-09-04 2003-01-07 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
SE9904673D0 (sv) 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE9904674D0 (sv) * 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE0001209D0 (sv) 2000-04-04 2000-04-04 Astrazeneca Canada Inc Novel compounds
AU2002305994B2 (en) * 2001-05-18 2008-06-26 Astrazeneca Ab 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
SE0203300D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203302D0 (sv) * 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203303D0 (sv) * 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0400027D0 (sv) * 2004-01-09 2004-01-09 Astrazeneca Ab Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
KR101234421B1 (ko) * 2004-08-02 2013-02-18 아스트라제네카 아베 디아릴메틸 피페라진 유도체, 이의 제조 방법 및 용도
SE0401968D0 (sv) * 2004-08-02 2004-08-02 Astrazeneca Ab Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
CA2724955A1 (en) * 2008-05-20 2009-11-26 Astrazeneca Ab Method of treating anxious major depressive disorder
KR101384638B1 (ko) * 2012-11-23 2014-04-14 한국타이어 주식회사 스노우 트랙션 성능과 관련한 패턴 성능 예측 모델

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2882271A (en) * 1959-04-14 Xcixcxh
CA601119A (en) * 1960-07-05 S. Yost Robert Preparation of unsaturated cyclic urea derivatives
US2766233A (en) * 1953-12-11 1956-10-09 Gen Aniline & Film Corp Polymethine dyes for synthetic fibers
GB1139934A (en) * 1966-08-18 1969-01-15 Delalande Sa Cinnamylpiperazine preparations
US3511841A (en) * 1967-05-29 1970-05-12 Sterling Drug Inc 1-((4-,5-,6-,and 7-azaindolyl)-lower-alkyl)- 4-substituted-piperazines
US3773939A (en) * 1971-11-24 1973-11-20 Janssen Pharmaceutica Nv N-arallyl-n'-aralkyl piperazine pharmaceutical compositions

Also Published As

Publication number Publication date
FR2234898B1 (cs) 1978-07-21
US3940386A (en) 1976-02-24
JPS6037095B2 (ja) 1985-08-24
AT340932B (de) 1978-01-10
NL184682B (nl) 1989-05-01
ATA539374A (de) 1977-05-15
CA1025452A (en) 1978-01-31
NL7408507A (cs) 1974-12-31
FR2234898A1 (cs) 1975-01-24
BE816984A (fr) 1974-10-16
GB1461689A (en) 1977-01-19
CH585209A5 (cs) 1977-02-28
JPS5036480A (cs) 1975-04-05
DE2431178A1 (de) 1975-01-16
NL184682C (nl) 1989-10-02
DE2431178C2 (de) 1985-10-24

Similar Documents

Publication Publication Date Title
AU465372B2 (cs)
AR201231Q (cs)
FR2234898B1 (cs)
AU471343B2 (cs)
AU465453B2 (cs)
AU465434B2 (cs)
AR201229Q (cs)
AU466283B2 (cs)
AR200885A1 (cs)
AU461342B2 (cs)
AR196382A1 (cs)
AU447540B2 (cs)
AU471461B2 (cs)
AR196123Q (cs)
CH563294A5 (cs)
BG19876A1 (cs)
CH567160A5 (cs)
CH567819A5 (cs)
CH565296A5 (cs)
CH565280A5 (cs)
CH567982A5 (cs)
CH563633A5 (cs)
BG18650A1 (cs)
CH562347A5 (cs)
CH561335A5 (cs)

Legal Events

Date Code Title Description
PL Patent ceased